Name |
Research Interests |
| |
| Frank
Burton, Ph.D. |
Transgenic modeling of cancer and
neurological diseases. |
| Colin
Campbell, Ph.D. |
Molecular
mechanisms of DNA repair and genome instability in mammalian
somatic cells. |
| Gregory
Connell, Ph.D. |
RNA editing in trypanosomes and
mammalian iron homeostasis. |
| Bianca
Conti-Fine, M.D. |
Molecular interactions occurring in human autoimmune
diseases between autoantigens and immune antigen receptors. |
Earl
Dunham, Ph.D. |
Synthesis and role of vasoactive autacoids in
regulation of the peripheral circulation. |
| Esam
El-Fakahany, Ph.D. |
Neuronal receptor modulation, mechanisms of
receptor coupling to second messenger signal transduction pathways,
and Alzheimer's disease. |
| Carolyn
Fairbanks, Ph.D. |
Development of novel compounds with a pharmacokinetic/dynamic
profile ideal for spinal delivery for pain relief. |
| S. Hossein Fatemi, M.D., Ph.D. |
The role of neurodevelopmental genes in etiology and treatment of schizophrenia, mood disorders and autism. |
| Patrick
Hanna, Ph.D. |
Biochemical studies of N-acetyltransferases;
bioactivation of arylamine carcinogens; drug metabolism; enzyme
inhibitors. |
| Hiroshi
Hiasa, Ph.D. |
Molecular basis of the cytotoxicity of topoisomerase-targeted anticancer and antimicrobial drugs, as well as identification of the factors that affect global gene expression and genomic stability. |
| Jordan
Holtzman, M.D., Ph.D. |
Biochemical problems in drug metabolism and
drug toxicity. |
| Donald Hunninghake, M.D. |
Professor Emeritus |
| Carol
Lange, Ph.D. |
Signal Transduction in Breast Cancer. |
| Ping-Yee
Law, Ph.D. |
Cellular regulation of opioid receptor signaling. |
| Fang Li , Ph.D. |
Invasion and replication mechanisms of human viral pathogens. |
| Horace
H. Loh, Ph.D. |
Frederick and Alice Stark Professor
and Head of Pharmacology. Neurochemical mechanisms
of opioids--major pain killers with addictive potential. |
| Jonathan
Marchant, Ph.D. |
Director of Graduate Studies. Spatial and temporal dynamics of intracellular
Ca2+ signals. |
| Kirill Martemyanov, Ph.D. |
Molecular and Cellular Mechanisms of G protein Signal Transduction. |
| Paul
Pentel, M.D., Ph.D. |
Mechanisms and treatment of drug toxicity. |
| Sundaram
Ramakrishnan, Ph.D. |
Tumor angiogenesis – Antiangiogenic Gene Therapy. |
| Daniel
Romero, Ph.D. |
Chromosome stability, telomerase structure and
function, and gene amplification. |
| Sabita
Roy, Ph.D. |
Molecular mechanism of morphine-induced immunosuppression. |
| Alan Sinaiko, M.D. |
Blood pressure/hypertension in children and adolescents. |
| Norman Sladek, Ph.D. |
Cancer chemotherapy, pharmacogenetics, drug metabolism, carcinogenesis, cancer chemoprevention, drug interactions, toxicology, cytochrome P450, aldehyde dehydrogenases, aldo-keto reductases and pharmacokinetics. |
| Sheldon
Sparber, Ph.D. |
Professor Emeritus |
| Stanley
Thayer, Ph.D. |
Drugs that modulate neurotoxicity and neuronal
signaling processes. |
| Timothy
Walseth, Ph.D. |
Regulation of calcium mobilization by cyclic
ADP-ribose and other nucleotides. |
| Elizabeth
Wattenberg, Ph.D. |
Mechanisms by which chemical carcinogens modulate
signal transduction pathways. |
| Li-Na
Wei, Ph.D. |
Regulatory pathways and mechanisms for adipocyte and neuronal differentiation. |
| Kevin
Wickman, Ph.D. |
Determining the mechanisms and behavioral consequences of synaptic
inhibition evoked by neurotransmitters and drugs of abuse. |
| George
Wilcox, Ph.D. |
Cellular and molecular mechanisms of neural
plasticity underlying chronic pain and analgesic tolerance
and dependence in the nervous system. |
| W.
Gibson Wood, Ph.D. |
Regulation and function of cholesterol in brain, its role in neurodegenerative diseases and neuroprotective mechanisms of cholesterol lowering drugs. |
| Douglas
Yee, M.D. |
Role of insulin-like growth factors in breast
cancer biology. |
| Yan Zeng, Ph.D. |
The biogenesis and function of regulatory RNAs. |
| Ben Zimmerman, Ph.D. |
Professor Emeritus |
